Using cancer's weapons against it

October 8, 2010 by Ed Sykes, Oxford University
Melanoma cells by nephron with gun by Steve Z.

(PhysOrg.com) -- Tumours seem to pacify our immune system by tapping into our bodies’ codes, but we may be able to use this trick against them in our bid to hunt them down.

Melanomas are not only one of the most aggressive types of human tumours but the cancerous are able to survive and proliferate despite the body’s best efforts to destroy them. Professor Vincenzo Cerundolo, Director of the MRC Human Immunology Unit at the University of Oxford, has been trying to establish how melanomas survive these attacks.

Our bodies are continuously fighting off infections and invading cells. We have many methods of defence at our disposal as part of our immune system - a huge, highly organised army complete with different types of troops and manoeuvres.

The ranks include a particularly potent type of cell called a neutrophil. Neutrophils are packed full of powerful enzymes that can destroy cells at the same time as recruiting reinforcements to the area (inflammation). But, as in any battle, there are always fears over friendly fire so the immune system can quickly issue messenger proteins that revert the troops to being passive so they don’t damage the body’s own cells.

The problem is that, as with any code used in war, the enemy can crack it. Vincenzo’s team recently discovered that melanomas have done just that as they also produce the messenger protein that signals inflammation to stop.

The protein concerned is called serum amyloid A (SAA) and it switches neutrophils from being aggressive to being anti-inflammatory. In other words, the melanomas seem to have evolved a way to manipulate the body’s own safety mechanisms so that they aren’t destroyed.

Unfortunately for melanomas though, producing anti-inflammatory neutrophils isn’t the protein’s only effect. The latest work from Vincenzo’s group, published in Nature Immunology, shows that SAA also affects another type of immune cell called an invariant natural killer T cell (iNKT) where it has exactly the opposite effect, jumpstarting the immune response by activating antibody-producing cells (B lymphocytes) and recruiting more cells capable of destroying tumours and virus infected cells (Killer T lymphocytes).

Vincenzo explains that 'SAA is used in the body to fine-tune the immune system, keeping the body alert to attack but stopping it from doing any unintended damage. The question of how melanomas can beat the immune system's defences has been asked for a really long time, and melanomas have many tricks up their sleeves, but we think their use of this protein is a really important one. But finding out that SAA also interacts with these iNKT cells was a really unexpected result and it means there’s a possible way of restoring the anti-tumour immune response.'

In healthy people the number of neutrophil cells is already an order of magnitude above iNKT cells, but in cancer patients there are even fewer iNKT cells to attack the tumours. Vincenzo says, 'it’s very early days but there are drugs that can promote activation of iNKT cells which we might be able to use to get patients’ immune systems to fight back.'

'Our bodies are set on the slightly cautious side as we don’t want our immune systems to damage the healthy parts of our body, but if we know what we’re doing we could activate the in the places and at the times that we need it. SAA is secreted during inflammation from any acute or chronic problem such as influenza or arthritis. If we can manipulate iNKT cells sufficiently it could be a very exciting prospect indeed, not just for cancer but for many other inflammatory diseases.'

More information: Paper: www.nature.com/ni/journal/vaop … nt/full/ni.1942.html

Related Stories

Recommended for you

Anemia discovery offers new targets to treat fatigue in millions

January 22, 2018
A new discovery from the University of Virginia School of Medicine has revealed an unknown clockwork mechanism within the body that controls the creation of oxygen-carrying red blood cells. The finding sheds light on iron-restricted ...

More surprises about blood development—and a possible lead for making lymphocytes

January 22, 2018
Hematopoietic stem cells (HSCs) have long been regarded as the granddaddy of all blood cells. After we are born, these multipotent cells give rise to all our cell lineages: lymphoid, myeloid and erythroid cells. Hematologists ...

How metal scaffolds enhance the bone healing process

January 22, 2018
A new study shows how mechanically optimized constructs known as titanium-mesh scaffolds can optimize bone regeneration. The induction of bone regeneration is of importance when treating large bone defects. As demonstrated ...

Researchers illustrate how muscle growth inhibitor is activated, could aid in treating ALS

January 19, 2018
Researchers at the University of Cincinnati (UC) College of Medicine are part of an international team that has identified how the inactive or latent form of GDF8, a signaling protein also known as myostatin responsible for ...

Bioengineered soft microfibers improve T-cell production

January 18, 2018
T cells play a key role in the body's immune response against pathogens. As a new class of therapeutic approaches, T cells are being harnessed to fight cancer, promising more precise, longer-lasting mitigation than traditional, ...

Weight flux alters molecular profile, study finds

January 17, 2018
The human body undergoes dramatic changes during even short periods of weight gain and loss, according to a study led by researchers at the Stanford University School of Medicine.

5 comments

Adjust slider to filter visible comments by rank

Display comments: newest first

fixer
not rated yet Oct 08, 2010
Now this is pleasing to see!
At last people are realising the value of the human immune system and are publishing their work.
Let's hope it filters quickly down to G.P. level and isn't blocked or spammed out by existing old world medicine.
Going
not rated yet Oct 09, 2010
"In other words, the melanomas seem to have evolved a way to manipulate the body’s own safety mechanisms so that they aren’t destroyed."

How can melanoma cells evolve? They have the same DNA as cells in the rest of the body. This is sloppy use of language.
Going
not rated yet Oct 09, 2010
The article says, ' In other words, the melanomas seem to have evolved a way to manipulate the body’s own safety mechanisms so that they aren’t destroyed. '

How can the melanoma cells evolve? They have same DNA as the rest of the cells in a human body. This is sloppy use of language.
JayW
not rated yet Oct 09, 2010
Actually the DNA in the melanoma is not the same. The cancer cells have accumulated mutations, which is what makes them cancerous. And they are multiplying rampantly and sloppily, giving more opportunities for mutation. The melanoma is indeed evolving, and quite rapidly. Like any evolving organism, the cancer cells can evolve defenses against poisons (such as chemotherapy drugs).
fixer
not rated yet Oct 09, 2010
It's the bacteria that cause the cancer that evolve,
similar bacteria infest the immune systems T cells and switch them off.
All this is established, but articles supporting it are very welcome.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.